---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-059115"
form_type: "8-K"
ticker: "NKTR"
cik: "0000906709"
company_name: "NEKTAR THERAPEUTICS"
filed_at: "2025-06-27T23:59:59+00:00"
generated_at: "2026-05-18T17:13:59.246410+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Nektar Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq deficiency notice on April 3, 2025 for bid price below $1.00.
- Regained compliance on June 23, 2025 after 10 consecutive trading days above $1.00.
- Nasdaq confirmed compliance in a letter dated June 24, 2025.
- Company continues to trade on The Nasdaq Capital Market under symbol NKTR.

## SEC filing metadata
- accession: 0001213900-25-059115
- form_type: 8-K
- ticker: NKTR
- cik: 0000906709
- company_name: NEKTAR THERAPEUTICS
- filed_at: 2025-06-27T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/906709/000121390025059115/0001213900-25-059115-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/906709/000121390025059115/ea0247333-8k_nektar.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-059115
- JSON: https://secwatch.observer/filing/0001213900-25-059115.json
- Plain text: https://secwatch.observer/filing/0001213900-25-059115.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.